Clinigence Holdings, Inc. Goes Public via a Reverse Merger With iGambit, Inc.
Summary
Clinigence is a pioneer in clinical quality reporting and population health analytics, and iGambit wholly owns HealthDatix, a healthcare technology company with a platform for optimizing annual wellness visits/health risk assessments (“AWV/HRA”) and chronic care management (“CCM”) as well as the BioDatix wearable device for remote patient monitoring. The former Clinigence directors are Jacob “Kobi” Margolin, Lawrence Schimmel, M.D., Mark Fawcett, MBA, Mitch Creem, David Meiri, Ph.D., Martin Breslin and Warren Hosseinion, M.D. “We are very pleased to announce the completion of our merger with iGambit to create one of the leading healthcare information technology companies in the nation,” stated Jacob “Kobi” Margolin, Chief Executive Officer of Clinigence. We’re helping to shape the future of our nation’s health care system, with robust leveraging of technology that delivers value-based healthcare and payment without extra staff or additional efforts on the part of the caregiver. Our proprietary data analytics management uncovers new opportunities for health wellness visits and 24/7/365 monitoring of people with chronic conditions.